- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02651480
A Nutritional Intervention in Police Officers
November 2, 2023 updated by: Physicians Committee for Responsible Medicine
The proposed study seeks to test the effect of a plant-based dietary intervention on cardiovascular risk factors in police officers.
Study Overview
Status
Suspended
Conditions
Intervention / Treatment
Detailed Description
This study tests the hypotheses that a low-fat, plant-based (vegan) diet improves body weight, plasma lipid concentrations, blood pressure, and, in individuals with type 2 diabetes, glycemic control, that a low-fat, plant-based diet improves health-related quality of life as measured by the Medical Outcomes Study Short Form 36-Item Health Survey (SF-36), and that a low-fat, plant-based diet improves mood, as measured by the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R).
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20016
- Physicians Committee for Responsible Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Men and women at least 18 years
- Body mass index ≥ 25 kg/m2 and/or a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥ 126 mg/dl on two occasions or a prior physician's diagnosis of type 2 diabetes
- Currently an employee of the Metropolitan Police Department of the District of Columbia
- Ability and willingness to participate in all components of the study
- A willingness to be randomly assigned to either study group
Exclusion Criteria:
- Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
- Use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
- Pregnancy
- Unstable medical or psychiatric illness
- Likely to be disruptive in group sessions (as determined by research staff)
- Already following a low-fat, vegan diet
- Lack of English fluency
- Inability or unwillingness to participate in all components of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vegan Group
Participants in the intervention group will follow a low-fat, plant-based diet for 14 weeks, and will attend nutrition classes in the form of a weekly support group.
|
Weekly instructions will be given to the participants in the intervention group about following vegan diet.
Other Names:
|
Active Comparator: Control Group
The control group will follow an unrestricted diet with no instruction.
|
Unrestricted diet with no instruction.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Weight
Time Frame: Changes in body weight from Baseline at 14 weeks
|
body weight will be measured to the nearest 0.1 kg, using a digital scale.
|
Changes in body weight from Baseline at 14 weeks
|
Plasma lipid concentrations
Time Frame: Changes in plasma lipid concentrations from Baseline at 14 weeks
|
will be measured using the Olympus Cholesterol Reagent on Olympus Chemistry Analyzers to assess changes in plasma lipid concentrations.
|
Changes in plasma lipid concentrations from Baseline at 14 weeks
|
Blood pressure
Time Frame: Changes in blood pressure from Baseline at 14 weeks
|
Blood pressure will be measured at each assessment
|
Changes in blood pressure from Baseline at 14 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life and Mood
Time Frame: Change in quality of life from Baseline at 4 months
|
Measured by a Modified Health Assessment Questionnaire (MHAQ).
The questionnaire measures the difficulty level of performing 8 different activities.
A score of 0 = the activity can be performed without difficulty.
A score of 3 = the activity cannot be performed.
The MHAQ is calculated as the average of these scores.
|
Change in quality of life from Baseline at 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Neal D Barnard, M.D., President
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
May 1, 2025
Study Registration Dates
First Submitted
January 7, 2016
First Submitted That Met QC Criteria
January 7, 2016
First Posted (Estimated)
January 11, 2016
Study Record Updates
Last Update Posted (Actual)
November 3, 2023
Last Update Submitted That Met QC Criteria
November 2, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PCRM MPD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaNot yet recruiting
Clinical Trials on Plant-based diet
-
University of MinnesotaCompleted
-
Montefiore Medical CenterThe Purjes Foundation; The Greenbaum FoundationRecruiting
-
University of UlsterFondazione Edmund MachCompletedMicrobiota | Nutrition, HealthyUnited Kingdom
-
George Washington UniversityNot yet recruitingInflammation | Hypertension | Diabetes Mellitus | Metabolic Syndrome | Dietary Habits | Kidney Disease, Chronic | Kidney Transplant Failure | Transplant Complication
-
Mayo ClinicCompleted
-
Charite University, Berlin, GermanyCharite University, Department for Dental MedicineCompletedMetabolic Syndrome | Overweight and Obesity | Cardiovascular Risk Factor | Hypertension,EssentialGermany
-
Vanderbilt University Medical CenterSeth BordensteinCompletedDiet Modification | Microbial ColonizationUnited States
-
Vascular Institute of TexasUnknownPeripheral Arterial DiseaseUnited States
-
Physicians Committee for Responsible MedicineNot yet recruiting
-
Physicians Committee for Responsible MedicineSibley Memorial HospitalCompleted